97 results on '"A. Katus Hugo"'
Search Results
2. Single high-sensitivity troponin sample below the limit of detection to safely rule out NSTEMI-ACS: is this enough?
3. European Society of Cardiology
4. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology
5. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
6. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)
7. Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis
8. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
9. Silencing of CCR2 in myocarditis
10. Atlas of the clinical genetics of human dilated cardiomyopathy
11. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study
12. 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease : The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC)
13. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
14. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
15. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial
16. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy
17. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction
18. Highly sensitive troponins knocking at the door of primary prevention
19. Myocardial injury in severe COVID-19 infection
20. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure
21. Altered HCN4 channel C-linker interaction is associated with familial tachycardia–bradycardia syndrome and atrial fibrillation
22. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model
23. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study
24. Third universal definition of myocardial infarction
25. European Society of Cardiology: cardiovascular disease statistics 2021.
26. How to use high-sensitivity cardiac troponins in acute cardiac care†
27. Recommendations for the use of natriuretic peptides in acute cardiac care†: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
28. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome
29. Why all the struggle about CK-MB and PCI?
30. Coexistence and outcome of coronary artery disease in Takotsubo syndrome
31. Recommendations for the use of cardiac troponin measurement in acute cardiac care†
32. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism
33. Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction
34. Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status
35. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction
36. Ability of DNase I activity to detect myocardial ischaemia in vasospastic angina—a view through a monocle?
37. †Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
38. Markers of myocardial ischaemia
39. Mirror, mirror on the wall: the quest for the earliest marker of myocardial ischaemia
40. Targeting coagulation in heart failure with preserved ejection fraction and cardiac fibrosis
41. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry
42. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY)
43. Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.
44. Accuracy of 0/1-hour algorithm for diagnosis of MI in the elderly: mono-dimensional optimization of troponin cut-offs for individual confounders or precision medicine?
45. TIMP-1: is surrogate testing for extracellular matrix remodelling ready for clinical translation or only an Icelandic phenomenon?
46. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy
47. Early diagnosis of acute coronary syndrome
48. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial
49. Inverse remodelling of K2P3.1 K+channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy
50. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.